Welcome to IsraPharm - Contact us at +972 7337 468 45 (Office)

Contact Us

Office Address

Weizman 14 st., Tel Aviv, Israel

Phone Number

+972 7337 46845 (Office)

Email Address

[email protected]



Add to Wishlist
Add to Wishlist


Zejula is a targeted drug from the PARP inhibitor group, prescribed for locally advanced or metastatic epithelial ovarian cancer, fallopian tube cancer, primary peritoneal cancer (peritoneal).

The drug is also approved for the treatment of castration-resistant metastatic prostate cancer, in combination with Abiraterone and prednisone.

Active ingredient: Niraparib

Prescription medicine

Additional information

Количество таблеток

56 Tab, 84 Tab